Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ALPANASDAQ:APYXNASDAQ:FEMYNASDAQ:HSAQ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALPAAlpha Healthcare Acquisition Corp. III$3.14$8.73▼$11.83$8.92M0.03128,666 shs85,427 shsAPYXApyx Medical$2.16-3.6%$1.50$0.76▼$2.30$81.64M1.2181,307 shs54,013 shsFEMYFemasys$0.98-0.3%$1.01$0.69▼$1.80$25.04M-2.62263,982 shs233,810 shsHSAQHealth Sciences Acquisitions Co. 2$2.78-6.7%$2.92$9.41▼$13.80$31.17M0.09205,918 shs3.19 million shs20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALPAAlpha Healthcare Acquisition Corp. III0.00%0.00%0.00%0.00%-63.04%APYXApyx Medical0.00%+8.00%+35.00%+66.15%+60.00%FEMYFemasys0.00%+15.29%-3.92%-24.03%-5.77%HSAQHealth Sciences Acquisitions Co. 2-6.71%-7.64%-5.76%-36.82%-59.48%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALPAAlpha Healthcare Acquisition Corp. IIIN/AN/AN/AN/AN/AN/AN/AN/AAPYXApyx Medical2.4406 of 5 stars0.05.00.04.22.21.70.6FEMYFemasys3.6646 of 5 stars3.55.00.00.03.22.50.6HSAQHealth Sciences Acquisitions Co. 2N/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALPAAlpha Healthcare Acquisition Corp. III 0.00N/AN/AN/AAPYXApyx Medical 2.67Moderate BuyN/AN/AFEMYFemasys 3.00Buy$8.67784.35% UpsideHSAQHealth Sciences Acquisitions Co. 2 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest ALPA, APYX, FEMY, and HSAQ Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/25/2025FEMYFemasysHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$12.006/11/2025FEMYFemasysHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$12.005/13/2025FEMYFemasysJones TradingSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$10.00 ➝ $6.005/9/2025FEMYFemasysHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $12.00(Data available from 6/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALPAAlpha Healthcare Acquisition Corp. IIIN/AN/AN/A923.23($0.31) per shareN/AAPYXApyx Medical$48.10M1.70N/AN/A$0.38 per share5.68FEMYFemasys$1.63M15.36N/AN/A$0.10 per share9.80HSAQHealth Sciences Acquisitions Co. 2N/AN/AN/AN/A($0.62) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALPAAlpha Healthcare Acquisition Corp. III$200KN/A0.00N/AN/AN/A-28.55%0.84%N/AAPYXApyx Medical-$23.46M-$0.55N/AN/AN/A-42.37%-156.85%-31.92%8/6/2025 (Estimated)FEMYFemasys-$18.82M-$0.91N/AN/AN/A-1,242.06%-392.45%-137.15%8/14/2025 (Estimated)HSAQHealth Sciences Acquisitions Co. 2-$380KN/A0.00∞N/AN/AN/A-2.38%N/ALatest ALPA, APYX, FEMY, and HSAQ EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025APYXApyx Medical-$0.13-$0.10+$0.03-$0.10$9.39 million$9.43 million5/8/2025Q1 2025FEMYFemasys-$0.17-$0.23-$0.06-$0.23$1.14 million$0.34 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALPAAlpha Healthcare Acquisition Corp. IIIN/AN/AN/AN/AN/AAPYXApyx MedicalN/AN/AN/AN/AN/AFEMYFemasysN/AN/AN/AN/AN/AHSAQHealth Sciences Acquisitions Co. 2N/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALPAAlpha Healthcare Acquisition Corp. IIIN/A0.050.05APYXApyx Medical3.215.454.64FEMYFemasys0.020.930.54HSAQHealth Sciences Acquisitions Co. 2N/A0.170.61Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALPAAlpha Healthcare Acquisition Corp. III67.49%APYXApyx Medical55.33%FEMYFemasys65.27%HSAQHealth Sciences Acquisitions Co. 289.71%Insider OwnershipCompanyInsider OwnershipALPAAlpha Healthcare Acquisition Corp. III0.39%APYXApyx Medical16.80%FEMYFemasys11.54%HSAQHealth Sciences Acquisitions Co. 221.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALPAAlpha Healthcare Acquisition Corp. III2,02119.31 millionN/ANot OptionableAPYXApyx Medical27037.79 million31.45 millionOptionableFEMYFemasys3025.55 million22.60 millionNot OptionableHSAQHealth Sciences Acquisitions Co. 2411.21 million8.76 millionNot OptionableALPA, APYX, FEMY, and HSAQ HeadlinesRecent News About These CompaniesCardinal Health inks 2 acquisitions worth $3.9BNovember 14, 2024 | healthcaredive.comHCardinal Health expands gastroenterology, diabetes businesses with two deals worth $3.9 billionNovember 12, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), Exact Sciences (EXAS) and Crispr Therapeutics AG (CRSP)November 6, 2024 | markets.businessinsider.comHealthStream acquires two companies for combined $2.2MNovember 6, 2024 | nashvillepost.comNHealthStream acquires two companies for combined $2.2 millionNovember 6, 2024 | nashvillepost.comNHealth companies backed by private-equity firms have 900 locations in the Philadelphia regionOctober 30, 2024 | inquirer.comIExact Sciences Corporation (EXAS): A Buzzing AI Health Stock to Add to Your PortfolioOctober 5, 2024 | msn.comWaud Capital snaps up health tech firm Science ExchangeOctober 1, 2024 | pehub.comHartford HealthCare seeks approval to take control of 2 surgical center operatorsSeptember 27, 2024 | hartfordbusiness.comHAcquisitions work as a one-time efficiency boost for hospital margins: studySeptember 27, 2024 | healthcaredive.comHUS healthtech company Syra closes $2.1m public offeringSeptember 16, 2024 | msn.comHealth plan performance dips on NCQA’s equity measuresSeptember 16, 2024 | modernhealthcare.comMQuest Completes Acquisition Of Select Laboratory Assets From Allina HealthSeptember 16, 2024 | markets.businessinsider.comRisant's Cone Health acquisition: 3 new detailsAugust 28, 2024 | beckershospitalreview.comBEarnings call: CV Sciences maintains revenue, eyes growth with acquisitionsAugust 15, 2024 | investing.comCommunity Health Systems, Inc. (CYH) Q2 2024 Earnings Call TranscriptJuly 25, 2024 | seekingalpha.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Healthequity (HQY), Community Health (CYH) and Gilead Sciences (GILD)July 25, 2024 | markets.businessinsider.comHealthcare & Life Sciences Private Equity Deal Tracker: Hamilton Lane Acquires Stake in Avista-Backed Cosette PharmaceuticalsJuly 22, 2024 | jdsupra.comBiogen joins immunology wave with $1.15 billion acquisitionMay 22, 2024 | statnews.comSHealthEquity Closes Conduent's BenefitWallet AcquisitionMay 17, 2024 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeALPA, APYX, FEMY, and HSAQ Company DescriptionsAlpha Healthcare Acquisition Corp. III NASDAQ:ALPAAlpha Healthcare Acquisition Corp. III does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in New York, New York.Apyx Medical NASDAQ:APYX$2.16 -0.08 (-3.57%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$2.17 +0.01 (+0.46%) As of 06/27/2025 06:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.Femasys NASDAQ:FEMY$0.98 0.00 (-0.33%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$0.96 -0.02 (-2.04%) As of 06/27/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.Health Sciences Acquisitions Co. 2 NASDAQ:HSAQ$2.78 -0.20 (-6.71%) As of 06/27/2025Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Broadcom’s Big VMware Update: A Threat to Public Cloud Giants? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
